Literature DB >> 32405157

The dilemmas of the classification of SARS-CoV-2 infection without clinical manifestations: Asymptomatic or presymptomatic.

Kovy Arteaga-Livias1, Samuel Pecho-Silva2, Vicky Panduro-Correa3, Alfonso J Rodríguez-Morales4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32405157      PMCID: PMC7218370          DOI: 10.1016/j.jfma.2020.05.009

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


× No keyword cloud information.
Dear Editor We have read the article by Cheng et al., about a case report of SARS-CoV-2/COVID-19 in Taiwan. As reported, the significant symptoms of that COVID-19 case were fever, dyspnea, and hypoxemia. However, their progression regarding fever appeared on day 5, dyspnea with mild hypoxemia, and radiographical pneumonia on day 9. Then, in this case, the time period from day 1 to day 4 is the pre-symptomatic phase of the disease. Sometimes it would be misleadingly interpreted as asymptomatic, and in certain conditions, deserve follow-up. Since the person-to-person transmission through respiratory droplets began to be recognized, one question is if asymptomatic patients may infectious to other people. Apparently viral loads in asymptomatic patients, compared to those symptomatic are similar. Reports from China assessing family clusters showed the index cases were asymptomatic. Nevertheless, many reported asymptomatic individuals developed disease over following days. They cannot be considered asymptomatic. Transmission can occur during the incubation period, these are presymptomatic.1, 2, 3 Presymptomatic transmission remains relevant for SARS-CoV-2 containment and isolation of infected people. Individuals developing symptoms should be diagnosed, isolated, and therefore tracing contacts and interruption of transmission chain should be performed. In addition, studies showing transmission from asymptomatic individuals indicate that ground-glass pattern lesions at CT-scans are found. This is a common finding COVID-19. This is an early sign disease of individuals able to transmit the virus. By strict criteria, only one reported case in published literature was genuinely asymptomatic. However, it is striking that the first positive result was 19 days after the trip to Wuhan, the epicenter of the epidemic, which, although it is within the maximum incubation times described, is, at least striking, the late appearance of the test positivity. On the other side of the question, there are also reports of patients, mainly first cases in regions where the disease had not been detected, which have been followed up and evaluated without finding evidence of asymptomatic transmission to the contacts, with demonstrated exposure. , Finally, it is essential to highlight that, given the research shown, the probability that asymptomatic patients can transmit the disease cannot be denied, however, given the low frequency of reports in this regard, likely, this mode of transmission is not the most important, so the containment of symptomatic patients and their contacts is the measure that can give better results in the search to reduce the burden of the disease in the affected countries.

Author contributions

All the authors substantially contributed to the conception, design, analysis, and interpretation of data, checking and approving the final version of the manuscript, and agree to be accountable for its contents.

Funding

None.

Declaration of Competing Interest

All authors declare that there exist no commercial or financial relationships that could, in any way, lead to a potential conflict of interest.
  4 in total

1.  Presumed Asymptomatic Carrier Transmission of COVID-19.

Authors:  Yan Bai; Lingsheng Yao; Tao Wei; Fei Tian; Dong-Yan Jin; Lijuan Chen; Meiyun Wang
Journal:  JAMA       Date:  2020-04-14       Impact factor: 56.272

2.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

Review 3.  Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.

Authors:  Chih-Cheng Lai; Yen Hung Liu; Cheng-Yi Wang; Ya-Hui Wang; Shun-Chung Hsueh; Muh-Yen Yen; Wen-Chien Ko; Po-Ren Hsueh
Journal:  J Microbiol Immunol Infect       Date:  2020-03-04       Impact factor: 4.399

4.  First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan.

Authors:  Shao-Chung Cheng; Yuan-Chia Chang; Yu-Long Fan Chiang; Yu-Chan Chien; Mingte Cheng; Chin-Hua Yang; Chia-Husn Huang; Yuan-Nian Hsu
Journal:  J Formos Med Assoc       Date:  2020-02-26       Impact factor: 3.282

  4 in total
  1 in total

Review 1.  Viral Replication and Antibody Kinetics in the Recognition of Asymptomatic COVID-19 Patients.

Authors:  Samuel Pecho-Silva; Ana Claudia Navarro-Solsol; Vicky Panduro-Correa; Ali A Rabaan; Jorge L Maguiña; Alfonso J Rodriguez-Morales; Kovy Arteaga-Livias
Journal:  Chemotherapy       Date:  2021-05-07       Impact factor: 2.544

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.